The American Society of Clinical Oncology includes PET and PET-CT overuse in list of Top Five procedures to avoid when clinical evidence is lacking.
The American Society of Clinical Oncology recently released its second list of Top Five tests, procedures, and treatments whose common use and clinical value are not support by available evidence. This list, part of the American Board of Internal Medicine Choosing Wisely Campaign, included avoiding the overuse of PET and PET-CT scanning to monitor for a cancer recurrence in patients who have finished initial treatment and have no signs of cancer.
ASCO first began its participation in Choosing Wisely in early 2013. The society’s original list also addressed the overuse of CT with two recommendations:
· Do not use PET, CT, and radionuclide bone scans in the staging of early breast cancer that is at low risk of spreading.
· Do not use PET, CT, and radionuclide bone scans in the staging of early prostate cancer at low risk of spreading.
“As physicians, we have a fundamental responsibility to provide high-quality, high-value cancer care for all of our patients,” said Lowell E. Schnipper, MD chair of ASCO’s Value of Cancer Care Task Force. “That means eliminating screening and imaging tests where the risk of harm outweighs the benefits, and making sure that every choice of treatment reflects the best available evidence. By providing evidence-based care, we not only help our patients live better with cancer, we also assure they are getting high-quality care that will deliver the greatest possible benefit for the cost.”
Computed tomography was also mentioned in several other society’s and organization’s lists published during the last several months. The American College of Emergency Physicians recommended that physicians avoid the use of CT in patients with minor head injuries who are deemed to be at low risk for skull fractures.
A joint list published by the American College of Chest Physicians and the American Thoracic Society recommended the avoidance of chest CT for (1) surveillance for evaluation of indeterminate pulmonary nodules at a greater frequency or longer duration than recommended by guidelines, (2) CT angiography for possibly pulmonary embolism in patients with low clinical probably and negative D-dimer assay results, and (3) for patients at low risk of lung cancer.
In February, The American Academy of pediatrics also recommended the elimination of unnecessary immediate CT scans in children with minor head injuries, in children with simple febrile seizure, and recommended against CT in the routine evaluation of abdominal pain.
More information about the campaign and a full list of Top Five lists can be found at www.choosingwisely.org.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.